Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q4 2021 · 10-K
Revenue$37.96M$37.96M+11.0% vs Q4 2020 Net Income$3.92M$3.92Mderivedno prior Q4 2020 on file EPS Diluted$0.74$0.74N/M vs Q4 2020 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
+31.8%
Operating Incomederived$4,668,000+327.5% Operating Cash Flowderived$13,520,000+53.1% Free Cash Flowderived$12,482,000+50.9% Margins · derivedGross margin65.2%+10.3 pt vs Q4 2020
Operating margin12.3%+9.1 pt vs Q4 2020
Net margin10.3%
ended Mar 31, 2021 · filed Jun 1, 2021 · 62 d after period end